Phase 3 DURAVYU insert misses key vision endpoint in wet AMD but cuts injections; pivotal LUCIA readout may decide its future ...
In this episode of The Retina TL;DR with Dr. Weng, powered by Modern Retina, host Christina Y. Weng, MD, MBA, FASRS, ...
Byron Lam, MD, and Benjamin Bakall, MD, PhD, discuss what an FDA approval of tinlarebant could mean for the Stargardt disease ...
COMO (NCT07449936) and CAPRI (NCT07449923), the two global Phase 3 trials of EYP-1901 vorolanib intravitreal insert (DURAVYU) ...
Cataract surgery often addresses one eye at a time, doubling patient travel and the use of resources, further elevating ...
In the latest episode of The Wills Retina Report, Dr. Regillo and Dr. Hsu discuss why sustained delivery with the port ...
Vezocolmitide (ST-100; Stuart Therapeutics) is a collagen mimetic peptide (CMP) therapy designed to seek out and repair ...
Woźniak, MD, PhD, discusses his real-world evidence study on a dry eye lubricating drop, including its effects on tear film ...
Since I started offering robotic laser cataract surgery, I have always been straightforward with patients, but it surprised me how much they lit up when they heard me say during a surgical ...
FDA clears OMNI Ultra Surgical System, adding single-pass canaloplasty to implant-free MIGS platform
Sight Sciences' newest MIGS device gains FDA clearance for single-pass canaloplasty and trabeculotomy in open-angle glaucoma.
The FDA has granted Priority Review to Belite Bio's NDA for tinlarebant in Stargardt disease type 1, positioning it as a ...
Robin A. Vora, MD, a retina specialist at Kaiser Permanente Oakland Medical Center, told Modern Retina that misdiagnosis of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results